EdgarLookup

iShares S&P GSCI Commodity-Indexed Trust — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that iShares S&P GSCI Commodity-Indexed Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
133.9%
Profit Margin
Net income ÷ revenue
7.1%
Return on Assets
Net income ÷ assets
0.01x
Debt-to-Equity
Total liabilities ÷ equity
-17%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $42.54M Feb 27, 2026
FY2025 Dec 31, 2024 $51.25M Feb 27, 2026
FY2025 Dec 31, 2023 $52.56M Feb 27, 2026
FY2024 Dec 31, 2022 $22.31M Feb 19, 2025
FY2023 Dec 31, 2021 $426.0K Feb 20, 2024
FY2022 Dec 31, 2020 $3.74M Feb 23, 2023
FY2021 Dec 31, 2019 $21.39M Mar 1, 2022
FY2020 Dec 31, 2018 $24.50M Mar 1, 2021
FY2019 Dec 31, 2017 $9.71M Feb 27, 2020
FY2018 Dec 31, 2016 $2.29M Feb 28, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $56.97M Feb 27, 2026
FY2025 Dec 31, 2024 $69.99M Feb 27, 2026
FY2025 Dec 31, 2023 ($66.54M) Feb 27, 2026
FY2024 Dec 31, 2022 $390.81M Feb 19, 2025
FY2023 Dec 31, 2021 $366.01M Feb 20, 2024
FY2022 Dec 31, 2020 ($183.62M) Feb 23, 2023
FY2021 Dec 31, 2019 $174.94M Mar 1, 2022
FY2020 Dec 31, 2018 ($190.21M) Mar 1, 2021
FY2019 Dec 31, 2017 $80.42M Feb 27, 2020
FY2018 Dec 31, 2016 $83.66M Feb 28, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $34.25M Feb 27, 2026
FY2025 Dec 31, 2024 $43.13M Feb 27, 2026
FY2025 Dec 31, 2023 $43.65M Feb 27, 2026
FY2024 Dec 31, 2022 $7.52M Feb 19, 2025
FY2023 Dec 31, 2021 ($10.39M) Feb 20, 2024
FY2022 Dec 31, 2020 ($2.28M) Feb 23, 2023
FY2021 Dec 31, 2019 $13.03M Mar 1, 2022
FY2020 Dec 31, 2018 $12.57M Mar 1, 2021
FY2019 Dec 31, 2017 ($160.5K) Feb 27, 2020
FY2018 Dec 31, 2016 ($5.10M) Feb 28, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($58.20M) Feb 27, 2026
FY2025 Dec 31, 2024 $69.56M Feb 27, 2026
FY2025 Dec 31, 2023 $183.77M Feb 27, 2026
FY2024 Dec 31, 2022 $565.06M Feb 19, 2025
FY2023 Dec 31, 2021 ($206.38M) Feb 20, 2024
FY2022 Dec 31, 2020 ($257.31M) Feb 23, 2023
FY2021 Dec 31, 2019 $630.67M Mar 1, 2022
FY2020 Dec 31, 2018 ($41.68M) Mar 1, 2021
FY2019 Dec 31, 2017 ($267.42M) Feb 27, 2020
FY2018 Dec 31, 2016 ($258.66M) Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $798.92M Feb 27, 2015
FY2014 Dec 31, 2013 $1.18B Feb 27, 2015
FY2013 Dec 31, 2012 $1.17B Feb 28, 2014

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $11.80M Feb 27, 2015
FY2014 Dec 31, 2013 $5.80M Feb 27, 2015
FY2013 Dec 31, 2012 $745.5K Feb 28, 2014

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $787.12M Feb 27, 2015
FY2014 Dec 31, 2013 $1.17B Feb 27, 2015
FY2014 Dec 31, 2012 $1.17B Feb 27, 2015
FY2014 Dec 31, 2011 $1.31B Feb 27, 2015
FY2013 Dec 31, 2010 $1.80B Feb 28, 2014

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $5.18M Feb 23, 2023
FY2022 Dec 31, 2021 $41.63M Feb 23, 2023
FY2022 Dec 31, 2020 $20.62M Feb 23, 2023
FY2022 Dec 31, 2019 $31.24M Feb 23, 2023
FY2021 Dec 31, 2018 $10.03M Mar 1, 2022
FY2020 Dec 31, 2017 $41.79M Mar 1, 2021
FY2019 Dec 31, 2016 $35.28M Feb 27, 2020
FY2018 Dec 31, 2015 $7.74M Feb 28, 2019
FY2017 Dec 31, 2014 $12.01M Feb 28, 2018
FY2016 Dec 31, 2013 $11.09M Feb 24, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 27, 2026
FY2025 Dec 31, 2024 1 Feb 27, 2026
FY2025 Dec 31, 2023 (1) Feb 27, 2026
FY2024 Dec 31, 2022 4 Feb 19, 2025
FY2023 Dec 31, 2021 4 Feb 20, 2024
FY2022 Dec 31, 2020 (3) Feb 23, 2023
FY2021 Dec 31, 2019 2 Mar 1, 2022
FY2020 Dec 31, 2018 (2) Mar 1, 2021
FY2019 Dec 31, 2017 1 Feb 27, 2020
FY2018 Dec 31, 2016 1 Feb 28, 2019